Market Tracker

04/21 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

104.39
Delayed Data
As of Apr 21
 -0.86 / -0.82%
Today’s Change
87.50
Today|||52-Week Range
139.79
+2.74%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close105.25
Today’s open105.21
Day’s range103.75 - 105.57
Volume128,614
Average volume (3 months)280,629
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+28.28%
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+51.53%
P/E ratioNM
Price/Sales19.42
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.02-0.05%
AGIOAgios Pharmaceutical...-1.29-2.67%
HCMHutchison China Medi...-0.18-0.97%
AXONAxovant Sciences Ltd-0.33-1.51%
Data as of 4:00pm ET, 04/21/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.75
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts